StockData
Lexicon Pharmaceuticals, Inc. logo

Lexicon Pharmaceuticals, Inc. (LXRX) stock

LXRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3087% above fair value
$1.72−0.06 (-3.37%)

Close on Nov 18, 2026Market cap $765.32MP/E –Yield –

Lexicon Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Lexicon Pharmaceuticals's market cap was $835.65M on Nov 11, 2026, against $523.07M a year earlier. Over the last 5 years it ranged from $167.28M to $1.02B, with a median of $396.10M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$835.65M+98.7%
2025Dec 31, 2025$420.65M+95.9%
2024Dec 31, 2024$214.70M-32.2%
2023Dec 29, 2023$316.60M+6.5%
2022Dec 30, 2022$297.29M-45.7%
2021Dec 31, 2021$547.75M+46.5%
2020Dec 31, 2020$374.01M-17.1%
2019Dec 31, 2019$451.19M-35.7%
2018Dec 31, 2018$702.16M-32.2%
2017Dec 29, 2017$1.04B-29.9%
2016Dec 30, 2016$1.48B+12.2%
2015Dec 31, 2015$1.32B+181.3%
2014Dec 31, 2014$467.94M-49.2%
2013Dec 31, 2013$920.95M-7.5%
2012Dec 31, 2012$995.09M–

More Lexicon Pharmaceuticals figures

See a number that looks wrong?